127 related articles for article (PubMed ID: 12361205)
1. Plasma levels of heparin cofactor II (HCII) and thrombin-HCII complex in patients with disseminated intravascular coagulation.
Noda A; Wada H; Kusiya F; Sakakura M; Onishi K; Nakatani K; Gabazza EC; Asahara N; Tsukada M; Nobori T; Shiku H
Clin Appl Thromb Hemost; 2002 Jul; 8(3):265-71. PubMed ID: 12361205
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of thrombin-heparin cofactor II complex in plasma from patients with disseminated intravascular coagulation.
Andersson TR; Sie P; Pelzer H; Aamodt LM; Nustad K; Abildgaard U
Thromb Res; 1992 Jun; 66(5):591-8. PubMed ID: 1523613
[TBL] [Abstract][Full Text] [Related]
3. Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
Kario K; Matsuo T; Kodama K; Katayama S; Kobayashi H
Thromb Res; 1992 May; 66(4):435-44. PubMed ID: 1412208
[TBL] [Abstract][Full Text] [Related]
4. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
Tran TH; Duckert F
Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
[TBL] [Abstract][Full Text] [Related]
5. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
[TBL] [Abstract][Full Text] [Related]
6. Heparin cofactor II activity in patients with disseminated intravascular coagulation and hepatic failure.
Tollefsen DM; Pestka CA
Blood; 1985 Oct; 66(4):769-74. PubMed ID: 4041618
[TBL] [Abstract][Full Text] [Related]
7. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders.
Takahashi H; Tatewaki W; Wada K; Hanano M; Shibata A
Am J Hematol; 1990 Feb; 33(2):90-5. PubMed ID: 1689102
[TBL] [Abstract][Full Text] [Related]
8. Increased ratio of soluble fibrin formation/thrombin generation in patients with DIC.
Kushimoto S; Wada H; Kawasugi K; Okamoto K; Uchiyama T; Seki Y; Hatada T; Imai H; Nobori T;
Clin Appl Thromb Hemost; 2012 Nov; 18(6):628-32. PubMed ID: 22751910
[TBL] [Abstract][Full Text] [Related]
9. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
[TBL] [Abstract][Full Text] [Related]
10. Hemostatic molecular markers before the onset of disseminated intravascular coagulation.
Wada H; Sakuragawa N; Mori Y; Takagi M; Nakasaki T; Shimura M; Hiyoyama K; Nisikawa M; Gabazza EC; Deguchi K; Kazama M; Shiku H
Am J Hematol; 1999 Apr; 60(4):273-8. PubMed ID: 10203100
[TBL] [Abstract][Full Text] [Related]
11. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
Watanabe R; Wada H; Watanabe Y; Sakakura M; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Nobori T; Shiku H
Thromb Res; 2001 Oct; 104(1):1-6. PubMed ID: 11583733
[TBL] [Abstract][Full Text] [Related]
12. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation.
Gando S; Nanzaki S; Sasaki S; Kemmotsu O
Thromb Haemost; 1998 Jun; 79(6):1111-5. PubMed ID: 9657433
[TBL] [Abstract][Full Text] [Related]
13. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.
Mei H; Jiang Y; Luo L; Huang R; Su L; Hou M; Wang X; Deng J; Hu Y
Thromb Res; 2019 Jan; 173():20-26. PubMed ID: 30458338
[TBL] [Abstract][Full Text] [Related]
14. Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues.
Kamp P; Strathmann A; Ragg H
Thromb Res; 2001 Mar; 101(6):483-91. PubMed ID: 11323006
[TBL] [Abstract][Full Text] [Related]
15. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
Seo JW; Kim HK; Kim JE; Park S; Cho HI
Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738
[TBL] [Abstract][Full Text] [Related]
16. Sickle cell disorders and chronic intravascular haemolysis are associated with low plasma heparin cofactor II.
Porter JB; Young L; Mackie IJ; Marshall L; Machin SJ
Br J Haematol; 1993 Mar; 83(3):459-65. PubMed ID: 8485052
[TBL] [Abstract][Full Text] [Related]
17. Hemostatic study before onset of disseminated intravascular coagulation.
Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi A; Mori Y; Deguchi K
Am J Hematol; 1993 Jul; 43(3):190-4. PubMed ID: 8352234
[TBL] [Abstract][Full Text] [Related]
18. The course of disseminated intravascular coagulation is predicted by changes in thrombin-antithrombin III complex levels--is there any difference between treatment with standard heparin or low-molecular-weight heparin?
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Blood Coagul Fibrinolysis; 1991 Oct; 2(5):623-7. PubMed ID: 1664251
[TBL] [Abstract][Full Text] [Related]
19. Prednisolone inhibits endotoxin-induced disseminated intravascular coagulation and improves mortality in rats: importance of inflammatory cytokine suppression.
Yamazaki M; Aoshima K; Mizutani T; Ontachi Y; Saito M; Morishita E; Asakura H; Matsuda T; Triplett DA
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):321-30. PubMed ID: 10493213
[TBL] [Abstract][Full Text] [Related]
20. Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Wada K; Niwano H; Shibata A
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):813-8. PubMed ID: 1336986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
